SCHEMBL27828809

SCHEMBL27828809

NC(=O)c1ccc(OCc2ccccn2)c(F)c1

nearest known ligand 0.63

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ PARP10 Q53GL7 1/20 0.63
▸ SYK P43405 11/20 0.55
▸ AURKB Q96GD4 2/20 0.53
▸ INCENP Q9NQS7 2/20 0.53
▸ BRD4 O60885 1/20 0.47
▸ LMNA P02545 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ FFAR1 O14842 1/20 0.45
▸ KMT2A Q03164 1/20 0.44
▸ ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4314016 0.89 SYK (0.58) PARP10SYKAURKBINCENPLMNA
SCHEMBL30151716 0.85 SYK (0.45) PARP10SYKBRD4LMNAHTT
SCHEMBL4319936 0.85 SYK (0.56) PARP10SYKAURKBINCENPBRD4
SCHEMBL2744895 0.81 PARP10 (0.59) PARP10LMNAHTTRAB9A
SCHEMBL30765139 0.80 PARP10 (0.68) PARP10LMNAHTTRAB9A
SCHEMBL29963339 0.79 SYK (0.65) SYKAURKBINCENPFFAR1
SCHEMBL6068690 0.79 SYK (0.65) SYKAURKBINCENPFFAR1
SCHEMBL6682997 0.77 PARP10 (1.00) PARP10
SCHEMBL29195674 0.76 CCR5 (0.51) SYKAURKBINCENPFFAR1
SCHEMBL30686435 0.76 SLC6A4 (0.57) SYKAURKBINCENPRAB9AFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102056594-B Pharmaceutical depot comprising N-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl}-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide ASTRAZENECA AB 2013-06-12 — — CN disclosed
CN-102056594-A Pharmaceutical depot comprising N-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl}-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide ASTRAZENECA AB 2011-05-11 — — CN disclosed
Send feedback